OPUS GENETICS

opus-genetics-logo

Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.

#SimilarOrganizations #People #Financial #Event #Website #More

OPUS GENETICS

Social Links:

Industry:
Health Care Health Diagnostics Wellness

Founded:
2004-01-01

Address:
Raleigh, North Carolina, United States

Country:
United States

Website Url:
http://www.opusgtx.com

Status:
Active

Contact:
919-525-9820

Total Funding:
19 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Sitelinks Search Box Yoast WordPress SEO Plugin


Similar Organizations

appliedvr-logo

AppliedVR

AppliedVR offers virtual reality-based therapeutic treatments that address the complexity of chronic pain.

careship-logo

Careship

Careship helps families find the right caregiver for their loved ones.

corsanitas-logo

CorSanitas

CorSanitas is a healthcare company that assists its members as they reverse their heart disease and any accompanying conditions.

daocloud-logo

DaoCloud

DaoCloud is the largest national network of vetted wellness practitioners.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

gojo-industries-logo

GOJO Industries

GOJO Industries is a company that offers health skin and hygiene solutions.

gravity-diagnostics-logo

Gravity Diagnostics

Gravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing.

healthpoint-plus-logo

HealthPoint Plus

HealthPoint Plus is disrupting the way patients access primary care with subscription-based medicine.

immunostics-logo

Immunostics

Immunostics offers a broad portfolio of diagnostics solutions.

infuse-holdings-logo

InFuse Holdings

InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers.

kikoko-logo

Kikoko

Kikoko is a cannabis botanical wellness company for women.

livwell-enlightened-health-logo

LivWell Enlightened Health

LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.

lyme-diagnostics-ltd-logo

Lyme Diagnostics Ltd.

Lyme Diagnostics offers reliable, standard diagnostic system for diagnosing Lyme borreliosis.

meetmindful-logo

MeetMindful

MeetMindful is a dating site platform for people who are into health, well-being, and mindfulness.

monument-logo

Monument

Monument is an alcohol addiction treatment platform for those looking to change their relationship with alcohol.

native-american-connections-nac-logo

Native American Connections (NAC)

Native American Connections (NAC) is an innovative multi-service organization working to improve community health and wellness

nice-recovery-systems-logo

NICE Recovery Systems

NICE Recovery Systems is a provider of therapy device to improve the convenience and efficacy of cold plus compression therapy.

oppimi-logo

Oppimi

Oppimi creates therapeutic tools for diagnosing and treating learning disabilities using a video-game approach.

opus-logo

OPUS

At-home wellness tech for emotional fitness

quit-genius-logo

Quit Genius

Quit Genius is a digital clinic for treating nicotine, alcohol, and opioid addictions.

seven-starling-logo

Seven Starling

Seven Starling is a digital clinic uniquely focused on treating perinatal mental health conditions.

squatty-potty-logo

Squatty Potty

An American personal care company

sunniva-logo

Sunniva

Sunniva is a vertically integrated medical company.

two-chairs-logo

Two Chairs

Two Chairs is a behavioral health company that operates a mental health therapy platform to offer in-person psychotherapy.

upside-health-logo

Upside Health

At Upside Health, weโ€™re transforming the way chronic pain is assessed and treated.

vision-healthcare-logo

Vision Healthcare

Vision Healthcare is a consumer healthcare company active in different European countries.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

not_available_image

Wallflowr

Wallflowr mission is to empower Networks to become resources for professional wellness for their growing communities.


Current Advisors List

rusty-kelley_image

Rusty Kelley Board Director @ Opus Genetics
Board_member
2021-01-01

jean-bennett_image

Jean Bennett Board Director @ Opus Genetics
Board_member

Current Employees Featured

joe-schachle_image

Joe Schachle
Joe Schachle Chief Operating Officer @ Opus Genetics
Chief Operating Officer

jennifer-hunt_image

Jennifer Hunt
Jennifer Hunt CDO @ Opus Genetics
CDO
2022-05-01

not_available_image

Ash Jayagopal
Ash Jayagopal Chief Scientific Officer @ Opus Genetics
Chief Scientific Officer

jason-d-menzo_image

Jason D. Menzo
Jason D. Menzo Co-Founder @ Opus Genetics
Co-Founder
2021-01-01

peter-ginsberg_image

Peter Ginsberg
Peter Ginsberg Co-Founder @ Opus Genetics
Co-Founder

benjamin-yerxa_image

Benjamin Yerxa
Benjamin Yerxa CEO @ Opus Genetics
CEO
2022-06-01

rusty-kelley_image

Rusty Kelley
Rusty Kelley Co-Founder & Board Director @ Opus Genetics
Co-Founder & Board Director
2021-01-01

jean-bennett_image

Jean Bennett
Jean Bennett Co-Founder @ Opus Genetics
Co-Founder

Founder


benjamin-yerxa_image

Benjamin Yerxa

jason-d-menzo_image

Jason D. Menzo

jean-bennett_image

Jean Bennett

peter-ginsberg_image

Peter Ginsberg

rusty-kelley_image

Rusty Kelley

Investors List

bios-partners_image

Bios Partners

Bios Partners investment in Seed Round - Opus Genetics

retinal-degeneration-fund_image

Retinal Degeneration Fund

Retinal Degeneration Fund investment in Seed Round - Opus Genetics

manning-family-foundation_image

Manning Family Foundation

Manning Family Foundation investment in Seed Round - Opus Genetics

Official Site Inspections

http://www.opusgtx.com Semrush global rank: 5.62 M Semrush visits lastest month: 1.51 K

  • Host name: 172.67.177.251
  • IP address: 172.67.177.251
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Opus Genetics"

Company Information :: Opus Genetics, Inc. (IRD) - ir.opusgtx.com

Investor Relations. LifeSci Advisors 250 West 55th Street, Suite 3401 New York, NY 10019 T: 646-889-1200 [email protected]See details»

Company Overview - Opus Genetics

Combined company advancing first-in-class retinal gene therapies. Ocuphire Pharma, Inc. and Opus Genetics have combined under the Opus Genetics name, and as a combined company, we are committed to building an innovative, โ€ฆSee details»

Corporate Governance :: Opus Genetics, Inc. (IRD) - ir.opusgtx.com

Committee List; Board Members Audit Compensation Nominating & Corporate Governance; Cam Gallagher, M.B.A.See details»

Opus Genetics - LinkedIn

Ocuphire Pharma, Inc. and Opus Genetics have combined under the Opus Genetics name (Nasdaq: IRD). As a combined company, we are committed to building an innovative, efficient and sustainable ...See details»

Opus Genetics - Crunchbase Company Profile & Funding

Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.See details»

George Magrath, MD, MBA, MS - Opus Genetics - opusgtx.com

Most recently, Dr. Magrath was CEO of Lexitas Pharma Services, a leading contract research organization in ophthalmology. Lexitas experienced a substantial growth in headcount, โ€ฆSee details»

Opus Genetics - VentureRadar

"Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Our AAV-based gene therapy portfolio, based on the work of โ€ฆSee details»

Opus Genetics Announces Financial Results for Third Quarter 2024 โ€ฆ

Nov 12, 2024 For more information, please visit www.opusgtx.com. Forward Looking Statements. This press release contains forward-looking statements within the meaning of the โ€ฆSee details»

Opus Genetics Leadership to Present at 3rd Annual Gene

Sep 12, 2022 RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-first gene therapy company developing treatments for inherited โ€ฆSee details»

Opus Genetics, Inc. (IRD)

Nov 12, 2024 The company is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to โ€ฆSee details»

Terms of Use - Opus Genetics

Oct 18, 2024 Opus Genetics Website Terms of Use Last Modified: October 18, 2024 Acceptance of the Terms of Use These terms of use are entered into by ...See details»

Financial Results :: Opus Genetics, Inc. (IRD) - ir.opusgtx.com

Jun 30, 2024 Fiscal Year Ended Dec 31, 2023. Earnings Release HTML. 10-K HTML XBRL ZipSee details»

Opus Genetics, Inc. /OLD/ (Opus Genetics, Inc. /OLD/) - ่ฏ็‰ฉ็ฎก็บฟ_ โ€ฆ

The resulting company will operate under the name Opus Genetics and the Nasdaq ticker symbol (IRD) RALEIGH, N.C., Oct. 25, 2024 /PRNewswire/ -- The RD Fund (Retinal Degeneration โ€ฆSee details»

Ocuphire Pharma Announces Acquisition of Opus Genetics

Oct 22, 2024 Back to OpusGTX.com ; Press Releases. Ocuphire Pharma Announces Acquisition of Opus Genetics. October 22, 2024 4:05 pm EDT Download as PDF Acquisition โ€ฆSee details»

Associate Director/Director Quality Manufacturing - opusgtx.com

Opus Genetics 223 South West Street, Suite 900 Raleigh NC 27603 opusgtx.com Associate Director/Director Quality Manufacturing About Opus This is an exciting opportunity to join โ€ฆSee details»

First Patient Dosed With LCA5 Gene Therapy - CGTliveโ„ข

Sep 19, 2023 Opus Genetics has dosed the first patient with Leber congenital amaurosis resulting from biallelic mutations in the LCA5 gene (LCA5) with the gene therapy OPGx-LCA5 โ€ฆSee details»

Patients & Families - Opus Genetics - opusgtx.com

Why gene therapy? Genetic mutations prevent production and/or appropriate function of the protein encoded by the gene. Opus Genetics is developing gene therapies to deliver a normal โ€ฆSee details»

Press Releases :: Opus Genetics, Inc. (IRD) - ir.opusgtx.com

Aug 8, 2024 Back to OpusGTX.com ; Press Releases. Year. Release Type. Nov 12, 2024 8:00 am EST. Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides โ€ฆSee details»

IRD Programs - Opus Genetics - opusgtx.com

OPGx-LCA5 . LCA5 is an early-onset retinal degeneration that affects approximately 200 people in the U.S. Evidence of a structural-functional dissociation in such individuals suggests an โ€ฆSee details»

linkstock.net © 2022. All rights reserved